{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:06:04Z","timestamp":1774973164234,"version":"3.50.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10741-020-10060-y","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:02:07Z","timestamp":1610582527000},"page":"781-797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Peripartum cardiomyopathy"],"prefix":"10.1007","volume":"26","author":[{"given":"Nivedita","family":"Jha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8968-9216","authenticated-orcid":false,"given":"Ajay Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"10060_CR1","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/01.CIR.44.5.964","volume":"44","author":"JG Demakis","year":"1971","unstructured":"Demakis JG, Rahimtoola SH (1971) Peripartum cardiomyopathy. Circulation 44:964\u2013968","journal-title":"Circulation"},{"key":"10060_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.CIR.44.6.1053","volume":"44","author":"JG Demakis","year":"1971","unstructured":"Demakis JG, Rahimtoola SH, Sutton GC et al (1971) Natural course of peripartum cardiomyopathy. Circulation 44:1053\u20131061","journal-title":"Circulation"},{"key":"10060_CR3","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/ejhf.586","volume":"18","author":"J Bauersachs","year":"2016","unstructured":"Bauersachs J, Arrigo M, Hilfiker-Kleiner D et al (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 18:1096\u20131105","journal-title":"Eur J Heart Fail"},{"key":"10060_CR4","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","volume":"283","author":"GD Pearson","year":"2000","unstructured":"Pearson GD, Veille GC, Rahimtoola S et al (2000) Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283:1183\u20131188","journal-title":"JAMA"},{"key":"10060_CR5","first-page":"311","volume":"94","author":"JU Hibbard","year":"1999","unstructured":"Hibbard JU, Lindheimer M, Lang RM (1999) A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 94:311\u2013316","journal-title":"Obstet Gynecol"},{"key":"10060_CR6","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/01.CIR.0000162478.36652.7E","volume":"111","author":"U Elkayam","year":"2005","unstructured":"Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A (2005) Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111:2050\u20132055","journal-title":"Circulation"},{"key":"10060_CR7","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1253\/circj.CJ-10-1214","volume":"75","author":"CA Kamiya","year":"2011","unstructured":"Kamiya CA, Kitakaze M, Ishibashi-Ueda H et al (2011a) Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders\u2014results from the Japanese Nationwide Survey of Peripartum Cardiomyopathy. Circ J 75:1975\u20131981","journal-title":"Circ J"},{"key":"10060_CR8","first-page":"228","volume":"17","author":"SA Isezuo","year":"2007","unstructured":"Isezuo SA, Abubakar SA (2007) Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 17:228\u2013233","journal-title":"Ethn Dis"},{"key":"10060_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","volume":"100","author":"SS Brar","year":"2007","unstructured":"Brar SS, Khan SS, Sandhu GK et al (2007) Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 100:302\u2013304","journal-title":"Am J Cardiol"},{"key":"10060_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1258\/td.2008.080353","volume":"39","author":"V Pandit","year":"2009","unstructured":"Pandit V, Shetty S, Kumar A, Sagir A (2009) Incidence and outcome of peripartum cardiomyopathy from a tertiary hospital in South India. Trop Doct 39:168\u2013169","journal-title":"Trop Doct"},{"key":"10060_CR11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4065\/80.12.1602","volume":"80","author":"JD Fett","year":"2005","unstructured":"Fett JD, Christie LG, Carraway RD, Murphy JG (2005) Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80:1602\u20131606","journal-title":"Mayo Clin Proc"},{"key":"10060_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jacc.2009.09.043","volume":"55","author":"MB Gentry","year":"2010","unstructured":"Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL (2010) African-American women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol 55:654\u2013659","journal-title":"J Am Coll Cardiol"},{"key":"10060_CR13","doi-asserted-by":"publisher","first-page":"e001056","DOI":"10.1161\/JAHA.114.001056","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS et al (2014) Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 3:e001056","journal-title":"J Am Heart Assoc"},{"key":"10060_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamacardio.2017.3574","volume":"2","author":"OC Irizarry","year":"2017","unstructured":"Irizarry OC, Levine LD, Lewey J et al (2017) Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women. JAMA Cardiol 2:1256\u20131260","journal-title":"JAMA Cardiol"},{"key":"10060_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jchf.2013.04.011","volume":"1","author":"DP Kao","year":"2013","unstructured":"Kao DP, Hsich E, Lindenfeld J (2013) Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail 1:409\u2013416","journal-title":"JACC Heart Fail"},{"key":"10060_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7326\/0003-4819-145-1-200607040-00007","volume":"145","author":"JD Fett","year":"2006","unstructured":"Fett JD, Christie LG, Murphy JG (2006) Brief communication: outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Intern Med 145:30\u201334","journal-title":"Ann Intern Med"},{"key":"10060_CR17","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jacc.2014.07.961","volume":"64","author":"U Elkayam","year":"2014","unstructured":"Elkayam U (2014) Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol 64:1629\u20131636","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10060_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJM200105243442101","volume":"344","author":"U Elkayam","year":"2001","unstructured":"Elkayam U, Tummala PP, Rao K et al (2001) Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344(21):1567\u20131571","journal-title":"N Engl J Med"},{"key":"10060_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/0002-9149(92)90369-A","volume":"70","author":"MA Mendelson","year":"1992","unstructured":"Mendelson MA, Chandler J (1992) Postpartum cardiomyopathy associated with maternal cocaine abuse. Am J Cardiol 70:1092\u20131094","journal-title":"Am J Cardiol"},{"key":"10060_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/AOG.0b013e318229e6de","volume":"118","author":"EP Gunderson","year":"2011","unstructured":"Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS (2011) Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol 118:583\u2013591","journal-title":"Obstet Gynecol"},{"key":"10060_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<22::AID-AJMG4>3.0.CO;2-3","volume":"91","author":"WE Bianchi","year":"2000","unstructured":"Bianchi WE (2000) Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 91:22\u201328","journal-title":"Am J Med Genet"},{"key":"10060_CR22","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","volume":"62","author":"N Bello","year":"2013","unstructured":"Bello N, Rendon ISH, Arany Z (2013) The relationship between preeclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 62:1715\u20131723","journal-title":"J Am Coll Cardiol"},{"key":"10060_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2010.08.065","volume":"154","author":"JG Safirstein","year":"2012","unstructured":"Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C (2012) Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol 154:27\u201331","journal-title":"Int J Cardiol"},{"key":"10060_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1067\/mob.2003.64","volume":"188","author":"KL Hogle","year":"2003","unstructured":"Hogle KL, Hutton EK, McBrien KA, Barrett JF, Hannah ME (2003) Cesarean delivery for twins: a systematic review and meta-analysis. Am J Obstet Gynecol 188:220\u2013227","journal-title":"Am J Obstet Gynecol"},{"key":"10060_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cardfail.2016.02.008","volume":"22","author":"M Afana","year":"2016","unstructured":"Afana M, Brinjikji W, Kao D et al (2016) Characteristics and in-hospital outcomes of peripartum cardiomyopathy diagnosed during delivery in the United States from the Nationwide Inpatient Sample (NIS) Database. J Card Fail 22:512\u2013519","journal-title":"J Card Fail"},{"key":"10060_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cardfail.2016.12.011","volume":"23","author":"A Barasa","year":"2017","unstructured":"Barasa A, Rosengren A, Sandstr\u00f6m TZ, Ladfors L, Schaufelberger M (2017) Heart failure in late pregnancy and postpartum: incidence and long-term mortality in Sweden from 1997 to 2010. J Card Fail 23:370\u2013378","journal-title":"J Card Fail"},{"key":"10060_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0002-9378(93)90479-3","volume":"168","author":"MB Lampert","year":"1993","unstructured":"Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang RM (1993) Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol 168:493\u2013495","journal-title":"Am J Obstet Gynecol"},{"key":"10060_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1385\/CRIAI:23:3:301","volume":"23","author":"AA Ansari","year":"2002","unstructured":"Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB (2002) Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 23:301\u2013324","journal-title":"Clin Rev Allergy Immunol"},{"key":"10060_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ajog.2005.01.022","volume":"193","author":"BD B\u00fcltmann","year":"2005","unstructured":"B\u00fcltmann BD, Klingel K, N\u00e4bauer M, Wallwiener D, Kandolf R (2005) High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193:363\u2013365","journal-title":"Am J Obstet Gynecol"},{"key":"10060_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/hrt.56.3.285","volume":"56","author":"JE Sanderson","year":"1986","unstructured":"Sanderson JE, Olsen EG, Gatei D (1986) Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 56:285\u2013291","journal-title":"Br Heart J"},{"key":"10060_CR31","doi-asserted-by":"crossref","unstructured":"Fett\u00a0JD (2006) Viral particles in endomyocardial biopsy tissue from peripartum cardiomyopathy patients.\u00a0Am J Obstet Gynecol 195:330\u20131, author reply 331\u20132","DOI":"10.1016\/j.ajog.2005.10.810"},{"key":"10060_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/0002-9149(94)90906-7","volume":"74","author":"MN Rizeq","year":"1994","unstructured":"Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME (1994) Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 74:474\u2013477","journal-title":"Am J Cardiol"},{"key":"10060_CR33","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.ejheart.2008.07.005","volume":"10","author":"O Forster","year":"2008","unstructured":"Forster O, Hilfiker-Kleiner D, Ansari AA et al (2008) Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 10:861\u2013868","journal-title":"Eur J Heart Fail"},{"key":"10060_CR34","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1172\/JCI69286","volume":"123","author":"Y Yang","year":"2013","unstructured":"Yang Y, Rodriguez JE, Kitsis RN (2013) A microRNA links prolactin to peripartum cardiomyopathy. J Clin Invest 123:1925\u20131927","journal-title":"J Clin Invest"},{"key":"10060_CR35","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/JCI64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein J, Tabruyn SP, Ricke-Hoch M et al (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 123:2143\u20132154","journal-title":"J Clin Invest"},{"key":"10060_CR36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00395-013-0366-9","volume":"108","author":"A Haghikia","year":"2013","unstructured":"Haghikia A, Podewski E, Libhaber E et al (2013) Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 108:366","journal-title":"Basic Res Cardiol"},{"key":"10060_CR37","first-page":"349","volume":"38","author":"B Stapel","year":"2017","unstructured":"Stapel B, Kohlhaas M, Ricke-Hoch M, Haghikia A, Erschow S, Knuuti J et al (2017) Low STAT3 expression sensitizes to toxic effects of \u03b2-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J 38:349\u2013361","journal-title":"Eur Heart J"},{"issue":"10","key":"10060_CR38","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/eurheartj\/ehq369","volume":"32","author":"A Haghikia","year":"2010","unstructured":"Haghikia A, Missol-Kolka E, Tsikas D et al (2010) Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J 32(10):1287\u20131297","journal-title":"Eur Heart J"},{"key":"10060_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY et al (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649\u2013658","journal-title":"J Clin Invest"},{"key":"10060_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten IS, Rana S, Shahul S et al (2012) Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485:333\u2013338","journal-title":"Nature"},{"key":"10060_CR41","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","volume":"123","author":"CE Powe","year":"2011","unstructured":"Powe CE, Levine RJ, Karumanchi SA (2011) Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123:2856\u20132869","journal-title":"Circulation"},{"key":"10060_CR42","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1253\/circj.CJ-10-1214","volume":"75","author":"CA Kamiya","year":"2011","unstructured":"Kamiya CA, Kitakaze M, Ishibashi-Ueda H et al (2011b) Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J 75:1975\u20131981","journal-title":"Circ J"},{"key":"10060_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tcm.2015.01.004","volume":"25","author":"NA Bello","year":"2015","unstructured":"Bello NA, Arany Z (2015) Molecular mechanisms of peripartum cardiomyopathy: a vascular\/hormonal hypothesis. Trends Cardiovasc Med 25:499\u2013504","journal-title":"Trends Cardiovasc Med"},{"key":"10060_CR44","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/hc3401.095947","volume":"104","author":"S Negoro","year":"2001","unstructured":"Negoro S, Kunisada K, Fujio Y et al (2001) Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia\/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 104:979\u2013981","journal-title":"Circulation"},{"key":"10060_CR45","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/nature06613","volume":"451","author":"Z Arany","year":"2008","unstructured":"Arany Z, Foo SY, Ma Y et al (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451:1008\u20131012","journal-title":"Nature"},{"key":"10060_CR46","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jchf.2016.01.004","volume":"4","author":"J Damp","year":"2016","unstructured":"Damp J, Givertz MM, Semigran M et al (2016) IPAC Investigators. Relaxin-2 and soluble Flt1 levels in peripartum cardiomyopathy: results of the multicenter IPAC study. JACC Heart Fail 4:380\u2013388","journal-title":"JACC Heart Fail"},{"key":"10060_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/phar.1548","volume":"35","author":"SS Wilson","year":"2015","unstructured":"Wilson SS, Ayaz S, Levy PD (2015) Relaxin: a novel agent for the treatment of acute heart failure. Pharmacotherapy 35:315\u2013327","journal-title":"Pharmacotherapy"},{"key":"10060_CR48","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/HYPERTENSIONAHA.110.165027","volume":"57","author":"JT McGuane","year":"2011","unstructured":"McGuane JT, Danielson LA, Debrah JE, Rubin JP, Novak J, Conrad KP (2011) Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans. Hypertension 57:1151\u20131160","journal-title":"Hypertension"},{"key":"10060_CR49","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/eurheartj\/ehi481","volume":"27","author":"K Sliwa","year":"2006","unstructured":"Sliwa K, F\u00f6rster O, Libhaber E et al (2006) Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27:441\u2013446","journal-title":"Eur Heart J"},{"key":"10060_CR50","doi-asserted-by":"publisher","first-page":"e4453","DOI":"10.1371\/journal.pone.0004453","volume":"4","author":"A Reddy","year":"2009","unstructured":"Reddy A, Suri S, Sargent IL, Redman CW, Muttukrishna S (2009) Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia. PLoS ONE 4:e4453","journal-title":"PLoS ONE"},{"key":"10060_CR51","doi-asserted-by":"publisher","first-page":"86.e1","DOI":"10.1016\/j.ajog.2014.07.021","volume":"212","author":"R Lim","year":"2015","unstructured":"Lim R, Acharya R, Delpachitra P et al (2015) Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies. Am J Obstet Gynecol 212:86.e1\u201312","journal-title":"Am J Obstet Gynecol"},{"key":"10060_CR52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2217\/14796678.5.2.175","volume":"5","author":"T Selle","year":"2009","unstructured":"Selle T, Renger I, Labidi S, Bultmann I, Hilfiker-Kleiner D (2009) Reviewing peripartum cardiomyopathy: current state of knowledge. Future Cardiol 5:175\u2013189","journal-title":"Future Cardiol"},{"key":"10060_CR53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ahj.2004.09.008","volume":"150","author":"RS Warraich","year":"2005","unstructured":"Warraich RS, Sliwa K, Damasceno A, Carraway R, Sundrom B et al (2005) Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J 150:263\u2013269","journal-title":"Am Heart J"},{"key":"10060_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0167-5273(02)00357-1","volume":"86","author":"JD Fett","year":"2002","unstructured":"Fett JD, Sundstrom BJ, Etta King M, Ansari AA (2002) Mother-daughter peripartum cardiomyopathy. Int J Cardiol 86:331\u2013332","journal-title":"Int J Cardiol"},{"key":"10060_CR55","doi-asserted-by":"publisher","first-page":"6515","DOI":"10.1001\/archinte.1963.03620290117016","volume":"111","author":"JA Pierce","year":"1963","unstructured":"Pierce JA, Price BO, Joyce JW (1963) Familial occurrence of postpartal heart failure. Arch Intern Med 111:6515","journal-title":"Arch Intern Med"},{"key":"10060_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman DS, Lam L, Taylor MR et al (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366:619\u2013628","journal-title":"N Engl J Med"},{"key":"10060_CR57","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1505517","volume":"374","author":"JS Ware","year":"2016","unstructured":"Ware JS, Li J, Mazaika E et al (2016) IMAC-2 and IPAC Investigators. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med 374:233\u2013241","journal-title":"N Engl J Med"},{"key":"10060_CR58","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1540-8159.2004.00483.x","volume":"27","author":"G Gemici","year":"2004","unstructured":"Gemici G, Tezcan H, Fak AS, Oktay A (2004) Peripartum cardiomyopathy presenting with repetitive monomorphic ventricular tachycardia. Pacing Clin Electrophysiol 27:557\u2013558","journal-title":"Pacing Clin Electrophysiol"},{"key":"10060_CR59","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/ejhf.780","volume":"19","author":"K Sliwa","year":"2017","unstructured":"Sliwa K, Mebazaa A, Hilfiker-Kleiner D et al (2017) Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail 19:1131\u20131141","journal-title":"Eur J Heart Fail"},{"key":"10060_CR60","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jacc.2010.02.076","volume":"56","author":"D Tanous","year":"2010","unstructured":"Tanous D, Siu SC, Mason J et al (2010) B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 56:1247\u20131253","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10060_CR61","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ejhf.1493","volume":"21","author":"J Bauersachs","year":"2019","unstructured":"Bauersachs J, K\u00f6nig T, van der Meer P et al (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 21(7):827\u2013843","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10060_CR62","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/14767058.2018.1494146","volume":"33","author":"M Biteker","year":"2020","unstructured":"Biteker M, \u00d6zlek B, \u00d6zlek E et al (2020) Predictors of early and delayed recovery in peripartum cardiomyopathy: a prospective study of 52 Patients. J Matern Fetal Neonatal Med 33(3):390\u2013397","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10060_CR63","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cjca.2015.07.733","volume":"32","author":"W Li","year":"2016","unstructured":"Li W, Li H, Long Y (2016) Clinical characteristics and long-term predictors of persistent left ventricular systolic dysfunction in peripartum cardiomyopathy. Can J Cardiol 32:362\u2013368","journal-title":"Can J Cardiol"},{"key":"10060_CR64","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/hrt.2006.087387","volume":"93","author":"CL Hu","year":"2007","unstructured":"Hu CL, Li YB, Zou YG, Zhang JM, Chen JB, Liu J et al (2007) Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 93:488\u2013490","journal-title":"Heart"},{"key":"10060_CR65","doi-asserted-by":"crossref","unstructured":"Talle MA, Buba F, Anjorin CO (2014) Prevalence and aetiology of left ventricular thrombus in patients undergoing transthoracic echocardiography at the University of Maiduguri Teaching Hospital. Adv Med 731936","DOI":"10.1155\/2014\/731936"},{"key":"10060_CR66","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0735-1097(99)00624-5","volume":"35","author":"K Sliwa","year":"2000","unstructured":"Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P (2000) Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas\/APO-1. J Am Coll Cardiol 35:701\u2013705","journal-title":"J Am Coll Cardiol"},{"key":"10060_CR67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2261-8-16","volume":"8","author":"KM Karaye","year":"2008","unstructured":"Karaye KM, Sani MU (2008) Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study. BMC Cardiovasc Disord 8:16","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"10060_CR68","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jchf.2014.10.008","volume":"3","author":"FV Lima","year":"2015","unstructured":"Lima FV, Parikh PB, Zhu J, Yang J, Stergiopoulos K (2015) Association of cardiomyopathy with adverse cardiac events in pregnant women at the time of delivery. JACC Heart Fail 3(3):257\u2013266","journal-title":"JACC Heart Fail"},{"key":"10060_CR69","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","volume":"66","author":"DM McNamara","year":"2015","unstructured":"McNamara DM, Elkayam U, Alharethi R et al (2015) IPAC investigators. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 66:905\u2013914","journal-title":"J Am Coll Cardiol"},{"key":"10060_CR70","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/ejhf.188","volume":"16","author":"D Duncker","year":"2014","unstructured":"Duncker D, Haghikia A, K\u00f6nig T et al (2014) Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter\/defibrillator. Eur J Heart Fail 16:1331\u20131336","journal-title":"Eur J Heart Fail"},{"key":"10060_CR71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cardfail.2011.09.004","volume":"18","author":"MT Saltzberg","year":"2012","unstructured":"Saltzberg MT, Szymkiewicz S, Bianco NR (2012a) Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 18:21\u201327","journal-title":"J Card Fail"},{"key":"10060_CR72","first-page":"1326","volume":"102","author":"SJ Whitehead","year":"2003","unstructured":"Whitehead SJ, Berg CJ, Chang J (2003) Pregnancy-related mortality due to cardiomyopathy: United States, 1991\u20131997. Obstet Gynecol 102:1326\u20131331","journal-title":"Obstet Gynecol"},{"key":"10060_CR73","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cardfail.2009.03.008","volume":"15","author":"S Goland","year":"2009","unstructured":"Goland S, Modi K, Bitar F et al (2009) Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 15:645\u2013650","journal-title":"J Card Fail"},{"key":"10060_CR74","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijcard.2017.02.084","volume":"235","author":"S Mallikethi-Reddy","year":"2017","unstructured":"Mallikethi-Reddy S, Akintoye E, Trehan N et al (2017) Burden of arrhythmias in peripartum cardiomyopathy: analysis of 9841 hospitalizations. Int J Cardiol 235:114\u2013117","journal-title":"Int J Cardiol"},{"key":"10060_CR75","doi-asserted-by":"crossref","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, et al (2018) ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 39(34):3165\u20133241","DOI":"10.1093\/eurheartj\/ehy478"},{"issue":"6","key":"10060_CR76","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jamainternmed.2017.0608","volume":"177","author":"L Duan","year":"2017","unstructured":"Duan L, Ng A, Chen W et al (2017) \u03b2-blocker exposure in pregnancy and risk of fetal cardiac anomalies. JAMA Intern Med 177(6):885\u2013887","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10060_CR77","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/1471-0528.12522","volume":"121","author":"AS Ersb\u00f8ll","year":"2014","unstructured":"Ersb\u00f8ll AS, Hedegaard M, S\u00f8ndergaard L, Ersb\u00f8ll M, Johansen M (2014) Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction. BJOG 121(5):618\u2013626","journal-title":"BJOG"},{"issue":"3","key":"10060_CR78","doi-asserted-by":"publisher","first-page":"e20160731","DOI":"10.1542\/peds.2016-0731","volume":"138","author":"BT Bateman","year":"2016","unstructured":"Bateman BT, Patorno E, Desai RJ et al (2016) Late pregnancy \u03b2 blocker exposure and risks of neonatal hypoglycemia and bradycardia. Pediatrics 138(3):e20160731","journal-title":"Pediatrics"},{"key":"10060_CR79","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et al (2016) Authors\/Task Force Members, Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891\u2013975","journal-title":"Eur J Heart Fail"},{"key":"10060_CR80","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijcard.2016.04.143","volume":"216","author":"A Haghikia","year":"2016","unstructured":"Haghikia A, Tongers J, Berliner D et al (2016) Early ivabradine treatment in patients with acute peripartum cardiomyopathy: subanalysis of the German PPCM registry. Int J Cardiol 216:165\u2013167","journal-title":"Int J Cardiol"},{"key":"10060_CR81","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ijcard.2015.04.081","volume":"190","author":"E Libhaber","year":"2015","unstructured":"Libhaber E, Sliwa K, Bachelier K, Lamont K, Bohm M (2015) Low systolic blood pressure and high resting heart rate as predictors of outcome in patients with peripartum cardiomyopathy. Int J Cardiol 190:376\u2013382","journal-title":"Int J Cardiol"},{"key":"10060_CR82","doi-asserted-by":"crossref","unstructured":"Sieweke\u00a0JT,\u00a0Pfeffer\u00a0TJ,\u00a0Berliner\u00a0D,\u00a0et al (2018) Cardiogenic shock complicating peripartum cardiomyopathy: importance of early left ventricular unloading and bromocriptine therapy.\u00a0Eur Heart J Acute Cardiovasc Care 2048872618777876","DOI":"10.1177\/2048872618777876"},{"key":"10060_CR83","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.accpm.2016.02.009","volume":"36","author":"I Labbene","year":"2017","unstructured":"Labbene I, Arrigo M, Tavares M et al (2017) Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy. Anaesth Crit Care Pain Med 36:39\u201342","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10060_CR84","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00392-010-0279-7","volume":"100","author":"M Biteker","year":"2011","unstructured":"Biteker M, Duran NE, Kaya H et al (2011) Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol 100:571\u2013577","journal-title":"Clin Res Cardiol"},{"key":"10060_CR85","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-2003-38897","volume":"29","author":"M Hellgren","year":"2003","unstructured":"Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29:125\u2013130","journal-title":"Semin Thromb Hemost"},{"key":"10060_CR86","first-page":"309","volume":"49","author":"AG Napporn","year":"2000","unstructured":"Napporn AG, Kane A, Damorou JM et al (2000) Intraventricular thrombosis complicating peri-partum idiopathic myocardiopathy. Ann Cardiol Angeiol (Paris) 49:309\u2013314","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10060_CR87","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejogrb.2005.03.009","volume":"123","author":"P Jha","year":"2005","unstructured":"Jha P, Jha S, Millane TA (2005) Peripartum cardiomyopathy complicated by pulmonary embolism and pulmonary hypertension. Eur J Obstet Gynecol Reprod Biol 123:121\u2013123","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10060_CR88","first-page":"e579","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J et al (2016) Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation 134:e579-646","journal-title":"Circulation"},{"key":"10060_CR89","doi-asserted-by":"publisher","first-page":"e0133466","DOI":"10.1371\/journal.pone.0133466","volume":"10","author":"NB Ntusi","year":"2015","unstructured":"Ntusi NB, Badri M, Gumedze F, Sliwa K (2015) Mayosi BM (2015) Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic peripartum cardiomyopathy. PLoS ONE 10:e0133466","journal-title":"PLoS ONE"},{"key":"10060_CR90","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","volume":"38","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D et al (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 38:2671\u20132679","journal-title":"Eur Heart J"},{"key":"10060_CR91","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","volume":"121","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Blauwet L, Tibazarwa K et al (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121:1465\u20131473","journal-title":"Circulation"},{"issue":"3","key":"10060_CR92","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00392-018-1355-7","volume":"108","author":"A Haghikia","year":"2019","unstructured":"Haghikia A, Schwab J, Vogel-Claussen J (2019) Bromocriptine Treatment in Patients with Peripartum Cardiomyopathy and Right Ventricular Dysfunction. Clin Res Cardiol 108(3):290\u2013297","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"10060_CR93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ehf2.12376","volume":"6","author":"M Tremblay-Gravel","year":"2019","unstructured":"Tremblay-Gravel M, Marquis-Gravel G, Avram R (2019) The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study. ESC Heart Fail 6(1):27\u201336","journal-title":"ESC Heart Fail"},{"issue":"12","key":"10060_CR94","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/ejhf.1624","volume":"21","author":"V Moulig","year":"2019","unstructured":"Moulig V, Pfeffer TJ, Ricke-Hoch M et al (2019) Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities. Eur J Heart Fail 21(12):1534\u20131542","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10060_CR95","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ejhf.808","volume":"19","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Masuko D et al (2017) Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. Eur J Heart Fail 19(12):1723\u20131728","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10060_CR96","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/2048872618777876","volume":"9","author":"JT Sieweke","year":"2020","unstructured":"Sieweke JT, Pfeffer TJ, Berliner D et al (2020) Cardiogenic shock complicating peripartum cardiomyopathy: importance of early left ventricular unloading and bromocriptine therapy. Eur Heart J Acute Cardiovasc Care 9(2):173\u2013182","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10060_CR97","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1388-9842(02)00008-9","volume":"4","author":"K Sliwa","year":"2002","unstructured":"Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P (2002) The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 4:305\u2013309","journal-title":"Eur J Heart Fail"},{"key":"10060_CR98","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/01.CIR.103.8.1083","volume":"103","author":"D Skudicky","year":"2001","unstructured":"Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P (2001) Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. Circulation 103:1083\u20131088","journal-title":"Circulation"},{"key":"10060_CR99","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/1755-5922.12076","volume":"32","author":"S Champion","year":"2014","unstructured":"Champion S, Lapidus N, Cheri\u00e9 G, Spagnoli V, Oliary J, Solal AC (2014) Pentoxifylline in heart failure: a meta-analysis of clinical trials. Cardiovasc Ther 32:159\u2013162","journal-title":"Cardiovasc Ther"},{"key":"10060_CR100","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jchf.2014.09.009","volume":"3","author":"RM Beadle","year":"2015","unstructured":"Beadle RM, Williams LK, Kuehl M et al (2015) Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy. JACC Heart Fail 3:202\u2013211","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10060_CR101","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1056\/NEJMoa1801291","volume":"381","author":"M Metra","year":"2019","unstructured":"Metra M, Teerlink JR, Cotter G et al (2019) Effects of serelaxin in patients with acute heart failure. N Engl J Med 381(8):716\u2013726","journal-title":"N Engl J Med"},{"key":"10060_CR102","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink JR, Cotter G, Davison BA et al (2013) RELAXin in acute heart failure (RELAX-AHF) investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381:29\u201339","journal-title":"Lancet"},{"key":"10060_CR103","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/ejcts\/ezu178","volume":"46","author":"M \u0141asi\u0144ska-Kowaraa","year":"2014","unstructured":"\u0141asi\u0144ska-Kowaraa M, Lango R, Kowalik M, Jarmoszewicz K\u0141 (2014) Accelerated heart function recovery after therapeutic plasma exchange in patient treated with biventricular mechanical circulatory support for severe peripartum cardiomyopathy. Eur J Cardiothorac Surg 46:1035\u20131036","journal-title":"Eur J Cardiothorac Surg"},{"key":"10060_CR104","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1681\/ASN.2015020157","volume":"27","author":"R Thadhani","year":"2016","unstructured":"Thadhani R, Hagmann H, Schaarschmidt W et al (2016) Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia. J Am Soc Nephrol 27:903\u2013913","journal-title":"J Am Soc Nephrol"},{"key":"10060_CR105","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cardfail.2011.09.004","volume":"18","author":"MT Saltzberg","year":"2012","unstructured":"Saltzberg MT, Szymkiewicz S, Bianco NR (2012b) Characteristics and outcomes of peripartum versus non-peripartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 18:21\u201327","journal-title":"J Card Fail"},{"key":"10060_CR106","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.healun.2011.11.018","volume":"31","author":"K Rasmusson","year":"2012","unstructured":"Rasmusson K, Brunisholz K, Budge D et al (2012) Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant 31:180\u2013186","journal-title":"J Heart Lung Transplant"},{"key":"10060_CR107","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bjaceaccp\/mkp032","volume":"9","author":"MR Davies","year":"2009","unstructured":"Davies MR, Cousins J (2009) Cardiomyopathy and anesthesia. Contin Educ Anaesth Crit Care Pain 9:189\u2013193","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10060_CR108","unstructured":"Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC, Hankins GDV, Clark SL (1997) Cesarean delivery and cesarean hysterectomy. Williams Obstetrics 20th edition, Cunningham et al, Appleton and Lange, Stamford, Conn, 509-531"},{"key":"10060_CR109","first-page":"1040","volume-title":"Principles and practice of medical therapy in pregnancy","author":"JT Perkins","year":"1992","unstructured":"Perkins JT (1992) Hemolytic disease of the newborn. In: Gleicher N (ed) Principles and practice of medical therapy in pregnancy, 2nd edn. Stamford Conn, Appleton & Lange, pp 1040\u20131045","edition":"2"},{"key":"10060_CR110","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.amjcard.2006.01.039","volume":"97","author":"LM Mielniczuk","year":"2006","unstructured":"Mielniczuk LM, Williams K, Davis DR et al (2006) Frequency of peripartum cardiomyopathy. Am J Cardiol 97:1765\u20131768","journal-title":"Am J Cardiol"},{"key":"10060_CR111","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1016\/j.jacc.2014.04.014","volume":"63","author":"J Pillarisetti","year":"2014","unstructured":"Pillarisetti J, Kondur A, Alani A et al (2014) Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use. J Am Coll Cardiol 63:2831\u20132839","journal-title":"J Am Coll Cardiol"},{"key":"10060_CR112","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","volume":"368","author":"K Sliwa","year":"2006","unstructured":"Sliwa K, Fett J, Elkayam U (2006) Peripartum cardiomyopathy. Lancet 368:687\u2013693","journal-title":"Lancet"},{"key":"10060_CR113","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.jacc.2012.11.057","volume":"61","author":"J Chen","year":"2013","unstructured":"Chen J, Dharmarajan K, Wang Y, Krumholz HM (2013) National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiol 61:1078\u20131088","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10060_CR114","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ahj.2006.02.008","volume":"152","author":"AM Amos","year":"2006","unstructured":"Amos AM, Jaber WA, Russell SD (2006) Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 152(3):509\u2013513","journal-title":"Am Heart J"},{"issue":"8","key":"10060_CR115","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/eurjhf\/hfs070","volume":"14","author":"M Biteker","year":"2012","unstructured":"Biteker M, Ilhan E, Biteker G, Duman D, Bozkurt B (2012) Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J Heart Fail 14(8):895\u2013901","journal-title":"Eur J Heart Fail"},{"key":"10060_CR116","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ejhf.1178","volume":"20","author":"K Sliwa","year":"2018","unstructured":"Sliwa K, Petrie MC, Hilfiker-Kleiner D et al (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peri- partum Cardiomyopathy. Eur J Heart Fail 20:951\u2013962","journal-title":"Eur J Heart Fail"},{"issue":"Suppl","key":"10060_CR117","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0735-1097(17)34231-6","volume":"69","author":"M Davis","year":"2017","unstructured":"Davis M, Kawamoto K, Langen E, Jackson E (2017) Breastfeeding is not associated with worse outcomes in peripartum cardiomyopathy. J Am Coll Cardiol 69(Suppl):842","journal-title":"J Am Coll Cardiol"},{"key":"10060_CR118","first-page":"291","volume":"4","author":"A Koczo","year":"2019","unstructured":"Koczo A, Marino A, Jeyabalan A et al (2019) Breastfeeding, cellular immune activation, and myocardial recovery in peripartum cardiomyopathy. J Am Coll Cardiol Basic Trans Science 4:291\u2013300","journal-title":"J Am Coll Cardiol Basic Trans Science"},{"key":"10060_CR119","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(13)60937-X","volume":"382","author":"RE Black","year":"2013","unstructured":"Black RE, Victora CG, Walker SP et al (2013) Maternal and child under nutrition and overweight in low-income and middle-income countries. Lancet 382:427\u2013451","journal-title":"Lancet"},{"key":"10060_CR120","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","volume":"387","author":"CG Victora","year":"2016","unstructured":"Victora CG, Bahl R, Barros AJ et al (2016) Breast- feeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387:475\u2013490","journal-title":"Lancet"},{"key":"10060_CR121","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.repc.2012.02.002","volume":"31","author":"MM Barbosa","year":"2012","unstructured":"Barbosa MM, Freire CM, Nascimento BR et al (2012) Rest left ventricular function and contractile reserve by dobutamine stress echocardiography in peripartum cardiomyopathy. Rev Port Cardiol 31:287\u2013293","journal-title":"Rev Port Cardiol"},{"key":"10060_CR122","unstructured":"Ostrzega E,\u00a0Elkayam U (1995) Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy: results of a survey. Circulation,\u00a092\u00a0SI: 333"},{"key":"10060_CR123","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0002-9378(97)80034-8","volume":"176","author":"M Lampert","year":"1997","unstructured":"Lampert M, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM (1997) Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 176:189\u2013195","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10060_CR124","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12872-018-0856-7","volume":"18","author":"NV Yam\u00e9ogo","year":"2018","unstructured":"Yam\u00e9ogo NV, Samadoulougou AK, Kagamb\u00e8ga LJ (2018) Maternal and fetal prognosis of subsequent pregnancy in Black African women with peripartum cardiomyopathy. BMC Cardiovasc Disord 18(1):119","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10060-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-020-10060-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10060-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T03:47:33Z","timestamp":1650253653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-020-10060-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10060"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-10060-y","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"30 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}